Market Tracker

04/26 2:53pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

0.6702
Delayed Data
As of 2:18pm ET
 +0.0135 / +2.06%
Today’s Change
0.63
Today|||52-Week Range
1.95
-35.56%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close0.66
Today’s open0.66
Day’s range0.64 - 0.67
Volume188,827
Average volume (3 months)614,592
Market cap$98.6M
Data as of 2:18pm ET, 04/26/2018

Growth & Valuation

Earnings growth (last year)+38.06%
Earnings growth (this year)+42.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-93.97%
P/E ratioNM
Price/Sales1,086.67
Price/Book2.80

Competitors

 Today’s
change
Today’s
% change
STDYSteadymed Ltd0.000.00%
GEMPGemphire Therapeutic...+0.22+3.83%
GLMDGalmed Pharmaceutica...-0.00-0.03%
GTXIGTX Inc-0.01-0.06%
Data as of 2:32pm ET, 04/26/2018

Financials

Next reporting dateMay 10, 2018
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$72.0K
Annual profit (last year)-$71.9M
Net profit margin-99,868.06%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, COO &
Director
Joseph P. Hagan
Chief Financial &
Accounting Officer
Daniel R. Chevallard
Corporate headquarters
San Diego, California

Forecasts